Larotrectinib is a pharmaceutical raw material and research compound used as a TRK kinase inhibitor in pharmaceutical manufacturing and laboratory studies. It features a complex polycyclic structure with aromatic rings and halogen substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1223403-58-4
Larotrectinib sulfate
pharmaceutical raw material
Islet amyloid polypeptide
pharmaceutical raw material
2-[(5-chloro-2-{[3-methyl-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}pyridin-4-yl)amino]-N-methoxybenzamide
pharmaceutical raw material
Protriptyline hydrochloride
pharmaceutical raw material
Faropenem sodium
pharmaceutical raw material
(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide
NYNZQNWKBKUAII-KBXCAEBGSA-N
C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F